Skip to main content
. 2022 Jan 21;13:811952. doi: 10.3389/fimmu.2022.811952

Table 1.

The accuracy of the model to distinguish severity group 2a or over from severity group 1 in the validation set.

A. Clinical data alone
Day True Severity Estimated S1 (n) Estimate S2a, 2b, 3 (n) Error Rate Accuracy
day 4-7 S1 (n) 8 1 0.11 0.93
S2a, 2b, 3 (n) 1 17 0.06
day 5-8 S1 (n) 5 5 0.50 0.82
S2a, 2b, 3 (n) 1 23 0.04
day 6-9 S1 (n) 9 2 0.18 0.92
S2a, 2b, 3 (n) 1 27 0.04
day 7-10 S1 (n) 9 3 0.25 0.89
S2a, 2b, 3 (n) 2 31 0.06
day 8-11 S1 (n) 6 6 0.50 0.76
S2a, 2b, 3 (n) 5 28 0.15
day 9-12 S1 (n) 7 4 0.36 0.88
S2a, 2b, 3 (n) 3 42 0.07
B. Clinical data + antibody data
Day True Severity Estimated S1 (n) Estimate S2a, 2b, 3 (n) Error rate (%) Accuracy
day 4-7 S1 (n) 6 3 0.33 0.74
S2a, 2b, 3 (n) 4 14 0.22
day 5-8 S1 (n) 5 5 0.50 0.85
S2a, 2b, 3 (n) 0 24 0.00
day 6-9 S1 (n) 8 3 0.27 0.92
S2a, 2b, 3 (n) 0 28 0.00
day 7-10 S1 (n) 8 4 0.33 0.89
S2a, 2b, 3 (n) 1 32 0.03
day 8-11 S1 (n) 5 7 0.58 0.82
S2a, 2b, 3 (n) 1 32 0.03
day 9-12 S1 (n) 7 4 0.36 0.91
S2a, 2b, 3 (n) 1 44 0.02